Difference between revisions of "P16"
Jump to navigation
Jump to search
(+refs) |
|||
| Line 19: | Line 19: | ||
*Prostate carcinoma. | *Prostate carcinoma. | ||
*Lung squamous cell carcinoma.<ref name=pmid25069600/> | *Lung squamous cell carcinoma.<ref name=pmid25069600/> | ||
==References== | |||
{{Reflist|1}} | |||
==External links== | ==External links== | ||
Revision as of 18:51, 12 March 2015
p16 is a commonly used immunostain. It can be considered a surrogate marker for HPV infection. p16, like most other "p" stains, is a nuclear stain.
Pattern
- Nuclear stain +/- cytoplasmic staining.
Use
- Squamous lesions of the uterine cervix - see HSIL.
- Head and neck squamous cell carcinoma, specifically human papillomavirus-associated head and neck squamous cell carcinoma.
Tumours
Positive
- Squamous cell carcinoma - esp. cervical SCC, anal SCC, penile SCC, HPV-associated head and neck SCC.
- High grade urothelial carcinoma ~86% of cases.[1]
Negative
- Breast carcinoma.
- Prostate carcinoma.
- Lung squamous cell carcinoma.[1]
References
- ↑ 1.0 1.1 Piaton, E.; Casalegno, JS.; Advenier, AS.; Decaussin-Petrucci, M.; Mege-Lechevallier, F.; Ruffion, A.; Mekki, Y. (Oct 2014). "p16(INK4a) overexpression is not linked to oncogenic human papillomaviruses in patients with high-grade urothelial cancer cells.". Cancer Cytopathol 122 (10): 760-9. doi:10.1002/cncy.21462. PMID 25069600.